In conclusion, our study demonstrates that three tumor biomarkers, including AFP, AFP‐L3, and GP73, can be used as prognostic factors for predicting the recurrence of HCC, but liver function tests seem to have better survival prediction values. This evidence concerns the gene AFP and hepatocellular carcinoma.